PR 13-2B Statement of cash flows-indirect method Obj. 2, 3, 4,5 The comparative balance sheet of...
The comparative balance sheet of Harris Industries Inc. at December
31, 20Y4 and 20Y3, is as follows:
An examination of the income
statement and the accounting records revealed the following
additional information applicable to 20Y4:
Net income, $524,580.
Depreciation expense reported on
the income statement: buildings, $51,660; machinery and equipment,
$22,680.
Patent amortization reported on the
income statement, $5,040.
A building was constructed for
$579,600.
A mortgage note for $224,000 was
issued for cash.
30,000 shares of common stock were...
Dec. 31, 2015 Dec. 2016 ASSETSCash ...
etod of presenting cash llows Irom PR 13-2B Statement of cash flows-indirect method ash flow ing activities, as follows: Obj. 2, 3, 4,5 from The comparative balance sheet of Harris Industries Inc, at December 31, 20Y4 and 20Y5, 1 cash flow $561,400 Assets Dec. 31, 20Y4 Dec. 31, 20Y3 Cash TEMPLATE Accounts receivable (net) $443,240 $360,920 592,200 1,022,560 Inventories 665,280 Prepaid expenses Land 887,880 25,200 302,400 1,134,000 (414,540) 781,200 31,640 302,400 Buildings 1,713,600 466,200) 781,200 (214,200) Accumulated depreciation-machinery and equipment.......
Statement of Cash Flows-Indirect Method The comparative balance sheet of Harris Industries Inc. at December 31, 2014 and 2043, is as follows: Dec. 31, Dec. 31, 2014 2013 Assets Cash Accounts receivable (net) Inventories Prepaid expenses $443,240 665,280 887,880 $360,920 592,200 1,022,560 31,640 25,200 Land 302,400 302,400 Buildings 1,713,600 (466,200) 1,134,000 (414,540) Accumulated depreciation-buildings Machinery and equipment Accumulated depreciation-machinery and equipment 781,200 (214,200) 106,960 $4,251,800 781,200 (191,520) 112,000 $3,724,420 Patents Total assets $837,480 32,760 Liabilities and Stockholders' Equity Accounts payable...
Statement of Cash Flows—Direct Method The comparative balance sheet of Martinez Inc. for December 31, 20Y4 and 20Y3, is as follows: Dec. 31, 20Y4 Dec. 31, 20Y3 Assets Cash $661,920 $683,100 Accounts receivable (net) 992,640 914,400 Inventories 1,394,400 1,363,800 Investments 0 432,000 Land 960,000 0 Equipment 1,224,000 984,000 Accumulated depreciation—equipment (481,500) (368,400) Total assets $4,751,460 $4,008,900 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $1,080,000 $966,600 Accrued expenses payable (operating expenses) 67,800 79,200 Dividends payable 100,800 91,200 Common stock, $5...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $260,120 $240,850 Accounts receivable (net) 94,230 86,500 Inventories 266,000 256,120 Investments 0 99,230 Land 136,440 0 Equipment 293,490 226,440 Accumulated depreciation-equipment (68,710) (61,060) Total assets $981,570 $848,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $177,660 $167,070 Accrued expenses payable (operating expenses) 17,670 22,050 Dividends payable 9,820 7,630 Common stock,...